Columvi
Active substance: glofitamab
SOLUTION, CONCENTRATE · GLOFITAMAB 2.5 mg/2.5mL
United StatesActive
Marketing holder: Genentech, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- GLOFITAMAB · 2.5 mg/2.5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-6009-7999-8671-223d4d7f0822,01a12098-bc20-777d-ad30-0abbeab960c7;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50242-125
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 50242-125 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50242-125 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50242-125 · Verified 2026-10-09 · open in source